ASX Share rice
Thu 06 Aug 2020 - 02:56:am (Sydney)

IDT Share Price

IDT AUSTRALIA LIMITEDIDTPharmaceuticals, Biotechnology & Life Sciences

IDT Company Information

Name:

IDT Australia Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

45 Wadhurst Drive Boronia VIC Australia 3155

Phone:

61 3 9801 8888

CEO & Joint Company Sec.:

Dr. David Sparling L.L.B., BVSc (Hons), GDipAppCGov, LLB (Hons)

VP of Operations, Supply & Infrastructure:

Mr. Jim Sosic

VP of People & Change:

Ms. Danielle Savaglio

CFO & Joint Company Sec.:

Ms. Ancila Desai

Head of Quality:

Mr. Daniel Broadhurst

Company Overview:

IDT Australia Limited engages in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and finished drug products worldwide. The company offers analytical method development, validation, and testing services for APIs, including cytotoxics, anti-cancer drugs, antibiotics, beta lactams, and controlled drugs, as well as generic medicines into finished dosage forms. Its services also include laboratory, functional support, project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. The company is headquartered in Boronia, Australia.

IDT Share Price Information

Shares Issued:

236.36M

Market Capitalisation:

$37.82M

Revenue (TTM):

$12.78M

Revenue Per Share (TTM):

$0.05

Earnings per Share:

$-0.025

Profit Margin:

-0.3814

Operating Margin (TTM):

$-0.28

Return On Assets (TTM):

$-0.07

Return On Equity (TTM):

$-0.19

Quarterly Revenue Growth (YOY):

0.1

Gross Profit(TTM):

$9.51M

Diluted Earnings Per Share (TTM):

$-0.02

IDT CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-871,000

Change To Liabilities:

$681K

Total Cashflow From Investing Activities:

$-871,000

Net Borrowings:

$-533,000

Net Income:

$-6,083,000

Total Cash From Operating Activities:

$-1,516,000

Depreciation:

$2.32M

Change To Inventory:

$67K

Change To Account Receivables:

$239K

Sale Purchase Of Stock:

$-1,644,000

Capital Expenditures:

$1.20M

IDT Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-6,119,000

Net Income:

$-6,083,000

Gross Profit:

$9.26M

Operating Income:

$-5,813,000

Other Operating Expenses:

$4.50M

Interest Expense:

$24K

Income Tax Expense:

$-36,000

Total Revenue:

$11.88M

Total Operating Expenses:

$15.08M

Cost Of Revenue:

$2.62M

IDT Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$1.11M

Total Liabilities:

$6.19M

Total Stockholder Equity:

$25.01M

Other Current Liabilities:

$3.87M

Total Assets:

$31.20M

Common Stock:

$51.19M

Retained Earnings:

$-31,724,000

Other Liabilities:

$1.23M

Other Assets:

$1.11M

Cash:

$9.50M

Total Current Liabilities:

$4.96M

Property - Plant & Equipment:

$16.68M

Net Tangible Assets:

$25.01M

Total Current Assets:

$13.42M

Long-Term Debt:

$5K

Net Receivables:

$2.23M

Short-Term Investments:

$17.78M

Inventory:

$664K

Accounts Payable:

$433K

Non Currrent Assets (Other):

$17.78M

Short-Term Investments:

$17.78

Non Current Liabilities Total:

$1.23M

IDT Share Price History

IDT News

15 Jul, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
17 Apr, 2020
IDT Australia Limited (ASX:IDT) shareholders will doubtless be very grateful to see the share price up 55% in the last...
23 Dec, 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

IDT Dividend Payments

EX-Date Dividend Amount
2010-04-12$0.0100